Singapore markets open in 3 hours 6 minutes

Cellectis S.A. (CLLS)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
2.5360-0.0240 (-0.94%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 187.74M
Enterprise value 204.33M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.08
Price/book (mrq)2.42
Enterprise value/revenue 270.64
Enterprise value/EBITDA -2.21

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 337.63%
S&P500 52-week change 323.10%
52-week high 33.7740
52-week low 30.9630
50-day moving average 32.6073
200-day moving average 32.3985

Share statistics

Avg vol (3-month) 339.17k
Avg vol (10-day) 341.32k
Shares outstanding 571.95M
Implied shares outstanding 673.73M
Float 839.06M
% held by insiders 19.40%
% held by institutions 117.20%
Shares short (15 Apr 2024) 4672.77k
Short ratio (15 Apr 2024) 421.96
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 40.94%
Shares short (prior month 15 Mar 2024) 4679.27k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,486.38%

Management effectiveness

Return on assets (ttm)-20.42%
Return on equity (ttm)-110.93%

Income statement

Revenue (ttm)9.19M
Revenue per share (ttm)0.16
Quarterly revenue growth (yoy)-88.50%
Gross profit (ttm)N/A
EBITDA -78.78M
Net income avi to common (ttm)-109.45M
Diluted EPS (ttm)-1.4100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)136.71M
Total cash per share (mrq)2.09
Total debt (mrq)105.86M
Total debt/equity (mrq)124.99%
Current ratio (mrq)1.50
Book value per share (mrq)1.30

Cash flow statement

Operating cash flow (ttm)-24.75M
Levered free cash flow (ttm)-19.84M